BIOA
Financials
- Market Capitalization 968.63 M
- Employee 62
- Founded 2015
- CEO N/A
- Website www.bioagelabs.com
- Headquarter Delaware, United States
- FIGI BBG00HBTB0M9
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2454 |  ETON Eton Pharmaceuticals, Inc. - Common Stock | 37.34 USD | +1.99% | -3.06% | +17.64% | +156.81% | 1.02 B USD | ||
| 2466 |  PCRX Pacira BioSciences, Inc. - Common Stock | 25.54 USD | +0.24% | -1.20% | +10.80% | +16.99% | 1.00 B USD | ||
| 2565 |  EVO Evotec SE - American Depositary Shares each representing 1/2 of | 2.43 USD | -12.90% | -14.44% | -13.83% | -43.09% | 864.01 M USD | ||
| 2576 |  AMPH Amphastar Pharmaceuticals, Inc. - Common Stock | 19.29 USD | +3.04% | -3.84% | -4.08% | -20.88% | 850.55 M USD |
Frequently asked questions about BioAge Labs, Inc. - Common Stock
What is the BioAge Labs, Inc. - Common Stock stock price today?
The current price of BioAge Labs, Inc. - Common Stock (BIOA) is 21.79. Over the past 24 hours, the stock has changed by -10.48%. Follow the BIOA chart for real-time price dynamics.
What is the stock ticker of BioAge Labs, Inc. - Common Stock?
BioAge Labs, Inc. - Common Stock trades under the ticker BIOA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is BioAge Labs, Inc. - Common Stock stock going up?
BIOA has changed by -10.59% over the last week, +19.14% over the last month, and +186.71% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was BioAge Labs, Inc. - Common Stock net income for the last quarter?
BioAge Labs, Inc. - Common Stock reported net income of -22.25 M for the last quarter. The previous quarter showed -25.94 M, which means net income changed by +14.22%.
How many employees does BioAge Labs, Inc. - Common Stock have?
As of the latest available data, BioAge Labs, Inc. - Common Stock has 62 employees. Workforce size can provide additional context about the company's scale and operations.
What is BioAge Labs, Inc. - Common Stock EBITDA?
BioAge Labs, Inc. - Common Stock EBITDA is -25.62 M, and its EBITDA margin is -924.17%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy BioAge Labs, Inc. - Common Stock stock?
You can buy BioAge Labs, Inc. - Common Stock (BIOA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in BioAge Labs, Inc. - Common Stock stock?
Investing in BioAge Labs, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BIOA chart and related analysis on metatrader.com as part of your research.